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Table 2
Age, BMI, gender distribution, and KL distribution for the progressors and non-
progressors.
Non-progressor (n ¼ 35) Progressor (n ¼ 22) P
Age (years) 44.1 (39.4, 48.7) 52.0 (46.7, 57.2) 0.028
BMI (kg/m2) 23.6 (22.8, 24.5) 24.0(22.5,25.6) 0.636
Men:Women 22:13 9:13 0.105*
KL KL0¼I3 (37.1 %);
KL 1¼14 (40%);
KL2 ¼ 6(17.1 %);
KL3 ¼ 2 (5.7%)
KL0¼2 (9.1%):
KL 1¼9 (40.9%);
KL2 ¼ 5 (22.7%);
KL3 ¼ 6 (27.3 %)
0.033*
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groups. Mixed-ANOVA was used to evaluate change in HOOS scores
over-time. Logistical regression was used to estimate the probability of
being classiﬁed as a progressor vs. non-progressor. Predictor variables
in the model included age, BMI, sex, pain, and the presence of radio-
graphic hip OA. Biomechanical data were available from a subgroup (n
¼ 52) who underwent 3-D gait analyses to quantify sagittal plane gait
mechanics during walking at the speed of 1.35 m/s at baseline and at 18
months. Multivariate ANOVA were used for differences in sagittal gait
parameters between progressors and non-progressors at baseline while
adjusting for age; and a 2nd logistic regression model was used to
analyze the association of walking speed, peak hip ﬂexion, and peak hip
extension with being a progressor vs. a non-progressor.
Results: The þROA group was older, with a higher proportion of sub-
jects with progression of BML and cysts, and a difference nearly sig-
niﬁcant for femoral cartilage lesions (Table 1, Figure 1).Table 1
Number (and percentage) of subjects with a progression of various MR structural
parameters in subjects with and without radiographic hip OA.
Number of subjects (%) -ROA
(n ¼ 38)
þROA
(n ¼ 19)
P value from
Fisher's Exact
test
Cartilage Lesions Overall Acetabular 3 (7.9 %) 2 (10.5%) 1.000
Overall Femoral 4 (10.5%) 6 (31.6%) 0.068
BML 1 (2.6 %) 4 (21.1 %) 0.038
Subchondral Cyst 0 5 (26.3 %) 0.003
Labrum 6 (15.8%) 4 (21.1 %) 1.000Figure 1. Proportion of compartments with progression of cartilage lesions
in both groups (-ROA etop, þROA ebottom) using illustration of hip joint
subregion subdivisions with color coding.
The HOOS scores were on average > 85% in both groups and the change
over time was not signiﬁcant between the 2 groups. 35 were classiﬁed
as non-progressors and 22 were classiﬁed as progressors (Table 2).
Logistic regression showed that male sex was associated with approx-
imately 83% lower probability of being classiﬁed as a progressor (Odds
ratio ¼ 0.17 (0.03-0.83); P ¼ 0.029); and having radiographic hip OA
(KL>1) was associated with an approximately 4.8 times greater risk of
progression (Odds Ratio ¼ 4.83 (1.03-22.62); P ¼ 0.046).
At baseline, the progressors ﬂexed their hips approximately 4.5 more
during early stance (P ¼ 0.021) and had a nearly signiﬁcant differences
in peak hip extension during late stance with the progressors extending
their hips approximately 3.5 less (P ¼ 0.059) (Figure 2).Figure 2. Baseline mean (standard deviation) for the non-progressors
(blue) and progressors (red). The * indicates statistical signiﬁcance at P <
0.05. The # indicates a P value between 0.05-0.1.Older age (Odds Ratio ¼
1.1, P ¼ 0.023) and greater peak hip ﬂexion angle (Odds Ratio ¼ 1.1, P ¼
0.024) were predictive of being a progressor. The progressor group
showed a nearly signiﬁcant decrease in the peak extension moment (P
¼ 0.056); and a decrease in sagittal him ROM (P ¼ 0.039) over 18
months.
Conclusions: These ﬁndings illustrate the pattern of morphological
progression of hip OA, and highlight the importance of MRI to detect
early degenerative disease in the hip. Non-modiﬁable risk factors
associated with hip OA progression include older age, female sex and
presence of radiographic hip OA. Potentially modiﬁable risk factors
include walking with greater hip ﬂexion. The results may guide future
interventions to alter the walking patterns to slow structural hip OA
progression.
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ENHANCED MRI OF TIBIOFEMORAL CARTILAGE (DGEMRIC) INDICES
AND CARTILAGE LOSS: A ONE-YEAR LONGITUDINAL STUDY USING
3.0T MRI
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Purpose: dGEMRIC is capable of detecting early changes in the glyco-
samoniglycan (GAG) content of cartilage, which may potentially lead to
changes in cartilage morphology. To date, there is no evidence that a
decrease in dGEMRIC indices over time, theoretically representing a
decrease in the GAG content of cartilage, is associatedwith cartilage loss
in the knee joint. The aim of this study was to assess the associations of
baseline dGEMRIC as well as changes in dGEMRIC indices with cartilage
loss in the same region of the knee over a one year period, in a sample of
middle-aged women.
Methods: A total of 140 women (1 knee per subject) aged  40 years
were prospectively included. 3.0T MRI of the knee was performed at
baseline and at one year follow-up. For cartilage morphology and
dGEMRIC assessments, the tibiofemoral compartments were divided in
four regions: medial (weight-bearing) femur, lateral (weight-bearing)
femur, medial tibia, and lateral tibia. T2-weighted fat-suppressed
sequences were used to assess cartilage morphology of the tibiofemoral
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tem. Two musculoskeletal radiologists read the images in pairs blinded
to the time point of acquisition. A 3D inversion recovery-prepared SPGR
sequence 90 minutes after intravenous gadolinium injection was
acquired for dGEMRIC assessment. Tibiofemoral cartilage from baseline
and follow-up MRIs was segmented by a trained fellow who was blin-
ded to the time point of acquisition. According to changes in dGEMRIC
indices from baseline to follow-up, three groups were deﬁned: decrease
(regions exhibiting any decrease of dGEMRIC), stable (regions exhibit-
ing stable indices), and increase dGEMRIC (regions exhibiting any
increase of dGEMRIC). Regarding changes of cartilage morphology from
baseline to follow-up, three groups were deﬁned: worsening (regions
exhibiting any increase in BLOKS score e cartilage loss), stable (regions
with stable BLOKS scores) and improvement (regions exhibiting any
decrease in BLOKS score). A decrease in dGEMRIC indices (decrease
dGEMRIC group) over one year was considered as the predictor of
cartilage loss. Co-variance analysis was performed to determine if
baseline dGEMRIC indices were different between regions with vs.
without cartilage loss. The association of any decrease in dGEMRIC
indices from baseline to follow-upwith cartilage loss in the same region
was assessed using logistic regression. In additionwe used the maximal
statistical approach to determine at which cut-off value baseline
dGEMRIC would be most predictive for cartilage loss after one year.
Results: A total of 434 regions from 140 knees were included: 25 (5.8%)
had cartilage loss over one year and 408 (92.2%) did not. Furthermore,
153 (35.3%) regions had a decrease in dGEMRIC indices over one year
and 280 (64.7%) did not. The mean baseline dGEMRIC index at the
lateral tibia was signiﬁcantly lower for regions exhibiting cartilage loss
over one year compared to regions without cartilage loss (484.7 ± 63.9
vs. 649.1 ± 140.7; p¼0.04). However, only 3 lateral tibial regions
exhibited cartilage loss over one year. No signiﬁcant differences in mean
baseline dGEMRIC were found in other tibiofemoral regions (Table 1).
No signiﬁcant associations between a decrease in dGEMRIC indices over
time and cartilage loss were observed (Table 2). A cut-off value of
baseline dGEMRIC predicting cartilage loss could not be established.
Conclusions: The association between a decrease in dGEMRIC over
time and cartilage loss in the tibiofemoral compartments over one yearTable 1
Differences in the mean baseline dGEMRIC indices in regions with progression of
cartilage loss vs. regions without progression of cartilage loss over one year. MF ¼
medial femur;MT¼medial tibia; LF¼ lateral femur; LT¼ lateral tibia; BL¼ baseline;
FU ¼ 1 year follow-up; SD ¼ standard deviation.
Regions Cartilage loss from BL to FU Baseline dGEMRIC p-value
N Mean (SD)
MF With cartilage loss (N¼16) 15 587.80 (114.23) 0.76
Without cartilage loss (N¼95) 94 597.54 (112.26)
MT With cartilage loss (N¼3) 3 518.33 (111.42) 0.35
Without cartilage loss (N¼109) 100 573.60 (99.45)
LF With cartilage loss (N¼4) 4 579.25 (98.39) 0.93
Without cartilage loss (N¼106) 106 584.31 (115.10)
LT With cartilage loss (N¼3) 3 484.67 (63.89) 0.046*
Without cartilage loss (N¼109) 109 649.05 (140.67)
Table 2
The associations of changes in dGEMRIC indices and progression of cartilage loss
over one year. *Adjusted for age, body mass index, and Kellgren-Lawrence grade o
radiographic OA. MF ¼ medial femur; MT ¼ medial tibia; LF ¼ lateral femur; LT ¼
lateral tibia; BL ¼ baseline; FU ¼ one year follow-up; OR ¼ odds ratio; CI ¼ con
ﬁdence intervals.
Region dGEMRIC changes
(from BL to FU)
Cartilage loss
(from BL to FU)
Crude OR
(95% CI)
Adjusted OR*
(95% CI)
Absence Presence
MF Stable or increase 53 (83%) 11 (17%) 1.0 (ref) 1.0 (ref)
Any decrease 38 (90%) 4 (10%) 0.5 (0.2, 1.7) 0.5 (0.1, 1.8)
MT Stable or increase 59 (97%) 2 (3%) 1.0 (ref) 1.0 (ref)
Any decrease 35 (97%) 1(3%) 0.8 (0.1, 9.6) 1.1 (0.1, 16.2)
LF Stable or increase 71 (96%) 3 (4%) 1.0 (ref) 1.0 (ref)
Any decrease 35 (97%) 1 (3%) 0.7 (0.1, 6.7) 0.6 (0.1, 6.7)
LT Stable or increase 70 (96%) 3 (4%) 1.0 (ref) 1.0 (ref)
Any decrease 39 (100%) 0 - -
Mean score ± STD, differentiated into medial, lateral and total menisci at BL and
FU
Medial Lateral Total
BL FU BL FU BL FU P-
value
Adolescent
athletes
0.3 ± 0.5 0.3 ± 0.6 0.0 ± 0.0 0.1 ± 0.5 0.3 ± 0.5 0.4 ± 0.9 0.187
Mature
athletes
1.1 ± 1.3 1.2 ± 1.4 0.8 ± 1.6 0.9 ± 1.6 1.9 ± 2.3 2.1 ± 2.3 0.042f
-could not be demonstrated in this sample of middle-aged women. Low
numbers of regions exhibiting cartilage loss and the challenge of deﬁ-
nition of change in dGEMRIC indices over time may have contributed to
these ﬁndings. Themonitoring of changes in dGEMRIC indices over time
still need to be validated before it can be applied as an imaging bio-
marker for longitudinal cartilage loss.
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Purpose: The aim of this study was to analyze the presence of structural
synovial tissue pathology by magnetic resonance imaging (MRI), in
young andmature volleyball athletes, and its longitudinal change over 2
years. These observations were compared with previously reported
prevalence rates in population-based studies.
Methods: Eighteen adolescent (8 male, 10 female, baseline age
16.0±0.8y) and 18 mature (9 male, 9 female, 46.8±5.1y) professional
volleyball athletes were studied. MR images (Coronal PD FS, Sagital 3D
VIBE, Axial T2 MEDIC) were acquired at baseline (BL) and at 2 year
follow-up (FU). From the 14 features of the WORMS scoring system,
cartilage signal and morphology, medial and lateral meniscal integrity,
and osteophytes were evaluated, and combined to compute a “total”
WOMRS score. These scores were derived for the medial femoro-tibial
joint (MFTJ), lateral femoro-tibial joint (LFTJ), patello-femoral joint
(PFJ), and the total knee joint. Post-hoc tests were conducted to test for
statistical signiﬁcances between the cohorts, as well as paired T-tests to
examine differences from BL to FU.
Results: Mature athletes showed a greater prevalence of cartilage and
meniscus lesions and osteophytes, resulting in a statistically greater
total WORMS score compared to the adolescent athletes (baseline:
adolescent athletes: 4.7 ± 4.6; mature athletes: 34.6 ± 30,6; follow-up:
6.7 ± 5.6 and 40.9 ± 30.3, respectively) (Figure 1, P <0.001). While the
adolescent athletes did not possess any incidence of cartilage pathology
neither at BL nor FU, the mature athletes show an increase from 7.6±9.5
at BL to 10.1±10.9 at FU (P¼0.012) in the total knee joint with the
greatest changes occurring in the LFTJ. Table 1 presents the ﬁndings in
the menisci that are increased in the medial, lateral as well as total knee
joint. Already within the 2 year follow-up period, the formation of
osteophytes increased statistically signiﬁcantly from 3.9 ± 2.9 at BL to
5.8 ± 3.4 at FU in adolescent athletes (P <0.01). A similar increase was
found in mature athletes, however from an elevated baseline level
(from 23.2 ± 15.7 at BL to 26.1 ± 15.8 at FU; P <0.001). The total WORMS
score increased from BL to FU in both cohorts (P<0.01 for adolescent
athletes).
Conclusions: These MRI-based ﬁndings indicate towards a signiﬁcant
change in structural tissue pathology due to athletic activity in the long-
term as well as already within a 2 year follow-up time. These changes
were of similar magnitude in adolescent and mature subjects, although
mature athletes started from substantially higher baseline values. The
comparison of the above WORMS scores and features with those pub-
lished in the literature shows that the values of the mature athletes fall
between those reported in healthy controls and osteoarthritic cohorts.
Additionally, other studies that investigated in patients with knee joint
problems show a trend to higher values in comparison to the values of
the mature athletes presented here. As anticipated, the values for the
adolescent athletes are much lower and not comparable to the other
